Jon was appointed to the Board as Chair on 1 September 2019.
Jon has extensive international financial, life sciences and governance experience.
Jon served as an Independent Non-Executive Director of HSBC Holdings plc from April 2014, and as Deputy Group Chairman from August 2018, until his retirement from the Board in February 2020. He was previously Chairman of HSBC Bank plc, Chief Financial Officer of Novartis AG, Partner and Managing Director of Goldman Sachs, Chief Financial Officer of AstraZeneca plc, and a Partner at KPMG. His governance experience includes roles as Non-Executive Director and Chair of the Audit Committees of Diageo plc and QinetiQ Group plc, Non-Executive Chair of Proteus Digital Health Inc and Non-Executive Director of Rubius Therapeutics, Inc.
Jon is a Fellow of the Institute of Chartered Accountants in England and Wales.
- Non-Executive Director, Genomics England Limited having previously served as its Chairman
- Non-Executive Chair, Energy Aspects
- Member, European Round Table for Industry
- Senior Advisor to Chatham House